6C42.3ICD-11 MMS 2026-01
Synthetic cannabinoid intoxication
Description
Synthetic cannabinoid intoxication is a clinically significant transient condition that develops during or shortly after the consumption of synthetic cannabinoids that is characterised by disturbances in consciousness, cognition, perception, affect, behaviour, or coordination. These disturbances are caused by the known pharmacological effects of synthetic cannabinoids and their intensity is closely related to the amount of synthetic cannabinoid consumed. They are time-limited and abate as synthetic cannabinoid is cleared from the body. Presenting features may include inappropriate euphoria, impaired attention, impaired judgment, perceptual alterations (such as the sensation of floating, altered perception of time), changes in sociability, increased appetite, anxiety, intensification of ordinary experiences, impaired short-term memory, and sluggishness. Physical signs include conjunctival injection (red or bloodshot eyes) and tachycardia. Intoxication with synthetic cannabinoids may also cause delirium or acute psychosis.
Index terms
- Synthetic cannabinoid intoxication
Exclusions from above levels
Sibling codes
6C42.0– Episode of harmful use of synthetic cannabinoids6C42.1– Harmful pattern of use of synthetic cannabinoids6C42.2– Synthetic cannabinoid dependence6C42.4– Synthetic cannabinoid withdrawal6C42.5– Synthetic cannabinoid-induced delirium6C42.6– Synthetic cannabinoid-induced psychotic disorder6C42.7– Certain specified synthetic cannabinoids-induced mental or behavioural disorders6C42.Y– Other specified disorders due to use of synthetic cannabinoids6C42.Z– Disorders due to use of synthetic cannabinoids, unspecified
Foundation entity
Synthetic cannabinoid intoxication – http://id.who.int/icd/entity/508603587
Allowed postcoordination axes
Part of: 6C42: Disorders due to use of synthetic cannabinoids › 06: Mental, behavioural or neurodevelopmental disorders